Quarterly report pursuant to Section 13 or 15(d)

Restricted Cash Equivalents and Investments (Schedule of Cash Equivalents and Available-for-Sale Securities) (Details)

v3.22.2.2
Restricted Cash Equivalents and Investments (Schedule of Cash Equivalents and Available-for-Sale Securities) (Details)
Sep. 30, 2022
USD ($)
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost $ 3,685,102
Gross Unrealized Losses (71,178)
Fair Value 3,613,924
Cash Equivalents 959,541
Short-Term Investments 2,654,383
Cash and Cash Equivalents [Member]  
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost 959,541
Fair Value 959,541
Cash Equivalents 959,541
Money Market Funds [Member]  
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost 959,541
Fair Value 959,541
Cash Equivalents 959,541
Investments [Member]  
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost 2,725,561
Gross Unrealized Losses (71,178)
Fair Value 2,654,383
Short-Term Investments 2,654,383
Corporate Notes/Bonds [Member]  
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost 2,725,561
Gross Unrealized Losses (71,178)
Fair Value 2,654,383
Short-Term Investments $ 2,654,383